Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and ...

DEAR DR. ROACH: A friend has been diagnosed with high blood calcium, and when I googled it, the results concerned me. Can you give information on this and how to discuss it with the doctor? I want to ...

Encaleret is an oral, small molecule designed to selectively modulate the calcium-sensing receptor protein to restore PTH secretion and calcium reabsorption.

BridgeBio Pharma is having a banner week, with the Bay Area company’s encaleret acing a phase 3 trial just days after another ...

DEAR DR. ROACH: I am an 85-year-old woman who is physically, mentally and socially active and in quite good health, except for osteoporosis issues. The only medications I take are Maxzide for blood ...

DEAR DR. ROACH: I am a 62-year-old white male who is 5 feet, 11 inches tall and weighs 205 pounds. I have diabetes, high blood pressure and high cholesterol. I was recently diagnosed with “moderate to ...